| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.2 | 0.4 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.19 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.064 | 0.4 |